24 Jan 2024 | 04:00 PM GMT

From Approval to Access and Adoption: Leveraging Real-World Data for Medical Devices

Participants:

Piotr Sokolowski Chief Medtech StrategistS3 Connected Health
Piotr Sokolowski
Chief Medtech StrategistS3 Connected Health
Julie Carty Head of GrowthHLTH Community
Julie Carty
Head of GrowthHLTH Community
Abdul Khaled Senior Director - Digital SolutionsWS Audiology
Abdul Khaled
Senior Director - Digital SolutionsWS Audiology
Aghogho Ekpruke Distinguished EngineerMedtronic
Aghogho Ekpruke
Distinguished EngineerMedtronic
Anupama Govindarajan Distinguished Regulatory AdvisorMedtronic
Anupama Govindarajan
Distinguished Regulatory AdvisorMedtronic
Bill Betten Director of Solutions - MedTechS3 Connected Health
Bill Betten
Director of Solutions - MedTechS3 Connected Health
Blaise Jacholkowski Senior Business Manager, Digital HealthZuhlke Group
Blaise Jacholkowski
Senior Business Manager, Digital HealthZuhlke Group
BRADLEY CARLSON ConsultantIndependent
BRADLEY CARLSON
ConsultantIndependent
Brenna Beluk Product Manager, Digital Health, ConsultantBoston Scientific
Brenna Beluk
Product Manager, Digital Health, ConsultantBoston Scientific
Frances Mitchell Director, Innovation Strategy and InsightTeleflex
Frances Mitchell
Director, Innovation Strategy and InsightTeleflex
Friedrich Wetterling Data Science and Research ManagerFIRE1
Friedrich Wetterling
Data Science and Research ManagerFIRE1
Gurdish Singh Portfolio Asset LeadPharmaceuticals
Gurdish Singh
Portfolio Asset LeadPharmaceuticals
Kathleen Van Vlierberghe VP, HealthCare Solutions & Partnerships EMEABoston Scientific
Kathleen Van Vlierberghe
VP, HealthCare Solutions & Partnerships EMEABoston Scientific
Marc Blanchard Founder & CEOATREON
Marc Blanchard
Founder & CEOATREON
Marko de Jager Principal ScientistPhilips Ambulatory Monitoring & Diagnostics
Marko de Jager
Principal ScientistPhilips Ambulatory Monitoring & Diagnostics
Mike Pace Founder & CEOPalmHealthCo
Mike Pace
Founder & CEOPalmHealthCo
Sandra Nagale Director, AI Partnerships & Digital HealthBoston Scientific
Sandra Nagale
Director, AI Partnerships & Digital HealthBoston Scientific
Sujai Kalra Director, Analytics & IntegrationsNevro
Sujai Kalra
Director, Analytics & IntegrationsNevro
Ventsislav Dobrev Global Clinical Lead Digital BiomarkersRoche
Ventsislav Dobrev
Global Clinical Lead Digital BiomarkersRoche
Yash Prajapati ConsultantZS Associates
Yash Prajapati
ConsultantZS Associates

About this Meeting

Collection of data in the real world is ubiquitous. Some of the medical device vendors fully utilize this trend while others are in the early stages of exploring how different data sources can support different use cases throughout the medical devices lifecycle.  


Real-world data (RWD) and evidence (RWE) can add new and supplementary insights on the performance of medical devices outside of the rigorously controlled confines of clinical trials. Additionally, the longitudinal nature of much of this data can provide greater insights into the safety and longer-term needs of patients. Furthermore, real-world data can support evidence on the fit-for-purposeness across additional use cases, not studied in early trials. Data collected in a real-world setting can serve to initiate a feedback loop, whereby providers and hospitals receive evidence that can serve to improve clinical practice.  

Join this roundtable in collaboration with S3 Connected Health, for which we will delve into three specific phases of the lifecycle and explore pragmatic considerations on leveraging RWD/RWE most effectively: 

  • Regulatory Approval: What types of real-world data are available for medical devices, and how can they be leveraged to improve patient outcomes? 
  • Market access: How can real-world data/evidence be used to support health technology assessment (HTA) and market access for medical devices, and what are the key considerations for payers and providers? 
  • Adoption and implementation: How can real-world evidence be used to support the adoption of medical devices by patients and integration into clinical workflows, and what are the key challenges and opportunities?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.